Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Pseudomonas aeruginosa attachment and biofilm development in dynamic environments.

Ramsey MM, Whiteley M.

Mol Microbiol. 2004 Aug;53(4):1075-87.

2.
3.

[Biofilm: set-up and organization of a bacterial community].

Filloux A, Vallet I.

Med Sci (Paris). 2003 Jan;19(1):77-83. Review. French.

4.

Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.

Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC, Matu JO.

Trends Microbiol. 2009 Mar;17(3):130-8. doi: 10.1016/j.tim.2008.12.003. Epub 2009 Feb 21. Review.

PMID:
19231190
5.

Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.

Bjarnsholt T, Tolker-Nielsen T, Høiby N, Givskov M.

Expert Rev Mol Med. 2010 Apr 7;12:e11. doi: 10.1017/S1462399410001420. Review.

PMID:
20370936
6.

Does Pseudomonas aeruginosa use intercellular signalling to build biofilm communities?

Kirisits MJ, Parsek MR.

Cell Microbiol. 2006 Dec;8(12):1841-9. Epub 2006 Oct 4. Review.

PMID:
17026480
7.

Surface-induced and biofilm-induced changes in gene expression.

Kuchma SL, O'Toole GA.

Curr Opin Biotechnol. 2000 Oct;11(5):429-33. Review.

PMID:
11024358
8.

[Research advances on regulation of Pseudomonas aeruginosa biofilm formation and its therapeutic strategies].

Wang WM, Xu ZH.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 Jan;39(1):103-8. Review. Chinese.

PMID:
20175245
9.

Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.

Hassett DJ, Cuppoletti J, Trapnell B, Lymar SV, Rowe JJ, Yoon SS, Hilliard GM, Parvatiyar K, Kamani MC, Wozniak DJ, Hwang SH, McDermott TR, Ochsner UA.

Adv Drug Deliv Rev. 2002 Dec 5;54(11):1425-43. Review.

PMID:
12458153
10.

Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.

Murray TS, Egan M, Kazmierczak BI.

Curr Opin Pediatr. 2007 Feb;19(1):83-8. Review.

PMID:
17224667
11.

Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa.

Mikkelsen H, Sivaneson M, Filloux A.

Environ Microbiol. 2011 Jul;13(7):1666-81. doi: 10.1111/j.1462-2920.2011.02495.x. Epub 2011 May 9. Review.

PMID:
21554516
12.

Bacterial biofilms: a common cause of persistent infections.

Costerton JW, Stewart PS, Greenberg EP.

Science. 1999 May 21;284(5418):1318-22. Review.

PMID:
10334980
13.
14.

Quorum sensing signals in development of Pseudomonas aeruginosa biofilms.

Parsek MR, Greenberg EP.

Methods Enzymol. 1999;310:43-55. Review. No abstract available.

PMID:
10547781
15.

Pseudomonas aeruginosa: all roads lead to resistance.

Breidenstein EB, de la Fuente-Núñez C, Hancock RE.

Trends Microbiol. 2011 Aug;19(8):419-26. doi: 10.1016/j.tim.2011.04.005. Epub 2011 Jun 12. Review.

PMID:
21664819
16.

Cystic fibrosis pathogenesis and the role of biofilms in persistent infection.

Costerton JW.

Trends Microbiol. 2001 Feb;9(2):50-2. Review.

PMID:
11173226
17.

Microbial pathogenesis and biofilm development.

Reisner A, Høiby N, Tolker-Nielsen T, Molin S.

Contrib Microbiol. 2005;12:114-31. Review. No abstract available.

PMID:
15496779
18.

Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa.

Häussler S.

Environ Microbiol. 2004 Jun;6(6):546-51. Review.

PMID:
15142242
19.

[Pseudomonas aeruginosa: characteristics of biofilm process].

Maianskiĭ AN, Chebotar' IV, Rudneva EI, Chistiakova VP.

Mol Gen Mikrobiol Virusol. 2012;(1):3-8. Review. Russian.

PMID:
22702137
20.

Molecular interactions in biofilms.

Shirtliff ME, Mader JT, Camper AK.

Chem Biol. 2002 Aug;9(8):859-71. Review.

Supplemental Content

Support Center